Medicare Enrolled
Dr. Sunil Gandhi, MD
Hematology · Lecanto, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gandhi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gandhi
Dr. Sunil Gandhi is a hematology in Lecanto, FL, with 19 years in practice. Based on federal Medicare data, Dr. Gandhi performed 389,163 Medicare services across 5,567 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gandhi received a total of $4,825 from 52 pharmaceutical and/or device companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gandhi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 3% volume in FL$ $4,825 industry payments
Medicare Practice Summary
Medicare Utilization ↗389,163
Medicare services
Top 3% in FL for hematology
5,567
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~20,482 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 75,480 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 67,860 | $0 | $2 |
| Filgrastim injection (Nivestym) for white blood cells | 61,200 | $0 | $1 |
| Nivolumab injection (Opdivo) | 31,774 | $24 | $72 |
| Epoetin alfa injection (Procrit) for anemia | 21,750 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 18,330 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 16,800 | $18 | $51 |
| Iron infusion (Injectafer) | 16,500 | $1 | $3 |
| Pembrolizumab injection (Keytruda) | 14,600 | $43 | $137 |
| Oxaliplatin chemotherapy injection | 12,600 | $0 | $12 |
| Immune globulin infusion (Gammagard) | 10,400 | $36 | $108 |
| Paclitaxel chemotherapy injection | 5,876 | $0 | $2 |
| Iron infusion (Monoferric) | 3,997 | $17 | $57 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,960 | $26 | $116 |
| Complete blood count (CBC) with differential | 3,878 | $8 | $29 |
| Blood draw (venipuncture) | 3,676 | $8 | $9 |
| Dexamethasone injection (steroid) | 3,383 | $0 | $3 |
| Office visit, established patient (30-39 min) | 2,459 | $96 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,010 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,886 | $11 | $69 |
| Injection, leucovorin calcium, per 50 mg | 1,677 | $3 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 1,260 | $0 | $9 |
| Office visit, established patient (20-29 min) | 1,065 | $66 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 847 | $22 | $84 |
| Administration of chemotherapy into vein, 1 hour or less | 821 | $97 | $378 |
| Injection, fluorouracil, 500 mg | 722 | $2 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 470 | $47 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 417 | $1 | $6 |
| Injection, carboplatin, 50 mg | 336 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 304 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 299 | $16 | $56 |
| Injection of additional new drug or substance into vein | 288 | $12 | $61 |
| Injection, zoledronic acid, 1 mg | 270 | $7 | $69 |
| Administration of additional new drug or substance into vein, 1 hour or less | 207 | $48 | $178 |
| Administration of chemotherapy into vein, each additional hour | 193 | $21 | $79 |
| Infusion into a vein for hydration, 31-60 minutes | 170 | $24 | $156 |
| Infusion, normal saline solution , 1000 cc | 152 | $2 | $7 |
| Administration of additional new drug or substance into vein using push technique | 140 | $42 | $170 |
| New patient office visit (45-59 min) | 138 | $122 | $453 |
| Office visit, established patient, complex (40-54 min) | 126 | $133 | $474 |
| Infusion into a vein for hydration, each additional hour | 118 | $10 | $42 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 109 | $1 | $7 |
| Red blood count automated, with additional calculations | 96 | $5 | $20 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 79 | $125 | $637 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 69 | $55 | $206 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 65 | $17 | $59 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 63 | $25 | $89 |
| Automated urinalysis | 58 | $2 | $8 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 57 | $15 | $56 |
| Drawing of blood for a medical problem | 44 | $68 | $277 |
| Injection of drug or substance into vein | 30 | $28 | $156 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 28 | $129 | $467 |
| Initial hospital admission, high complexity | 26 | $137 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.9% high complexity
69.0% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,825
Total received (2018-2024)
Avg $689/year across 7 years
Bottom 40% in FL for hematology
52
Companies
243
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,567 (94.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$258 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,521
2023$831
2022$872
2021$130
2020$175
2019$975
2018$321
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$416
E.R. Squibb & Sons, L.L.C.
$401
PFIZER INC.
$344
Merck Sharp & Dohme LLC
$268
Novartis Pharmaceuticals Corporation
$251
Lilly USA, LLC
$166
Incyte Corporation
$165
Genentech USA, Inc.
$154
Alexion Pharmaceuticals, Inc.
$150
GENZYME CORPORATION
$135
Amgen Inc.
$133
Merz North America, Inc.
$132
Gilead Sciences, Inc.
$131
Daiichi Sankyo Inc.
$123
Merck Sharp & Dohme Corporation
$122
Kite Pharma, Inc.
$116
Janssen Biotech, Inc.
$114
Regeneron Healthcare Solutions, Inc.
$110
Seattle Genetics, Inc.
$108
BeiGene USA, Inc.
$96
Astellas Pharma US Inc
$92
EISAI INC.
$82
Seagen Inc.
$69
Eisai Inc.
$64
ABBVIE INC.
$58
Bayer HealthCare Pharmaceuticals Inc.
$54
Karyopharm Therapeutics Inc.
$52
TESARO, Inc.
$51
TerSera Therapeutics LLC
$50
Blueprint Medicines Corporation
$50
Takeda Pharmaceuticals U.S.A., Inc.
$47
CTI BioPharma Corp.
$46
PUMA BIOTECHNOLOGY, INC.
$44
Aveo Pharmaceuticals, Inc.
$40
ARRAY BIOPHARMA INC
$35
EMD Serono, Inc.
$28
Pharmacyclics LLC, An AbbVie Company
$27
Stemline Therapeutics Inc.
$25
PharmaEssentia USA Corporation
$25
Mirati Therapeutics, Inc.
$23
Tempus AI, Inc
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
Deciphera Pharmaceuticals Inc.
$21
Puma Biotechnology, Inc.
$20
Jazz Pharmaceuticals Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
Hologic Sales and Service, LLC
$18
Rigel Pharmaceuticals, Inc.
$18
Dendreon Pharmaceuticals LLC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
ADC Therapeutics America, Inc.
$17
Advanced Accelerator Applications
$15
Top 3 companies account for 24.1% of total payments
Associated products mentioned in payments ›
ACESSA PROVU SYSTEM · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · AYVAKIT · Aliqopa · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CHANTIX · COSELA · CYRAMZA · DARZALEX · ELREXFIO · EMPLICITI · EVENITY · EXKIVITY · Enhertu · Erleada · FOTIVDA · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lutathera · MEKINIST · MONJUVI · MVASI · NERLYNX · Nplate · OPDIVO · OPDUALAG · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Padcev · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · SANDOSTATIN · SARCLISA · Stivarga · TECENTRIQ · TUKYSA · Tavalisse · Trodelvy · Ultomiris · VENCLEXTA · VERZENIO · Vitrakvi · Vonjo · XALKORI · XEOMIN · XPOVIO · XT CDX · XTANDI · Xermelo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $1 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
9
Per 100K population
5.7
County median income
$55,355
Nearest hospital
HCA FLORIDA CITRUS HOSPITAL
7.4 mi
7.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gandhi is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gandhi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Gandhi performed 75,480 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gandhi receive payments from pharmaceutical companies?
Yes. Dr. Gandhi received a total of $4,825 from 52 companies across 243 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gandhi's costs compare to other hematologys in Lecanto?
Dr. Gandhi's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gandhi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Lecanto
Browse hematologys in Lecanto ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology